Artal Group S.A. Portfolio Holdings

Artal Group S.A.

  • $101 Million
  • Q4 2024

Artal Group S.A. has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $101 Million distributed in 2 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Lexicon Pharmaceuticals, Inc. with a value of $101M and Cava Group Inc with a value of $0.

Examining the 13F form we can see an decrease of $113M in the current position value, from $214M to 101M.

Artal Group S.A. is based out at Luxembourg, N4

Below you can find more details about Artal Group S.A. portfolio as well as his latest detailed transactions.

Portfolio value $101 Million
Healthcare: $101 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$132M
$101 Million 100.0% of portfolio
136,180,481
Q3 2024 Reduced 22.23%
Cava Group Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 45.69%

Summary

  • Portfolio
  • No. of Stocks 2
  • Current Value $101 Million
  • Prior Value $214 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email